Back to comparisons

Comparison

Nicotinamide Riboside (NR) vs Resveratrol

FieldNicotinamide Riboside (NR)Resveratrol
Categoryneuroprotectiveneuroprotective
Dose range250–1000mg250–500mg
Half-life9h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs25016000

The comparison in plain English

Auto-generated from data

Nicotinamide Riboside (NR) and Resveratrol are both in the neuroprotective category respectively. Nicotinamide Riboside (NR) NAD+ precursor — the most-studied form for direct NAD+ elevation in humans. Resveratrol Polyphenol from grape skins and Japanese knotweed.

Bottom line

Nicotinamide Riboside (NR) (evidence A, safety 5/5) has a weaker evidence base than Resveratrol (evidence B, safety 5/5). Nicotinamide Riboside (NR) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Nicotinamide Riboside (NR) if

Nicotinamide Riboside (NR) is the better fit when your goal aligns with its mechanism (Precursor in the NAD+ salvage pathway via NRK1 and NRK2 enzymes that phosphorylate NR to NMN, which then converts to NAD+) and the dose range (250–1000mg) suits your protocol. Half-life is —h.

Choose Resveratrol if

Resveratrol is the better fit when your goal aligns with its mechanism (Activates SIRT1 (sirtuin 1), the longevity-associated histone deacetylase that mediates calorie restriction's lifespan extension in model organisms) and the dose range (250–500mg) suits your protocol. Half-life is 9h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →